All In MedTech

Device Trial Radar · NCT04553523

Hydrus® Microstent New Enrollment Post-Approval Study

The Hydrus® Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm, Clinical Trial

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

545

Planned (sponsor's estimate)

Start

Aug 25, 2020

Primary completion

Oct 2028

Study completion Oct 2028

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Sep 17, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.

Conditions

  • Primary Open Angle Glaucoma

Interventions

  • Hydrus MicrostentDevice

    Crescent-shaped nitinol device intended as a permanent implant to provide an outflow pathway for aqueous humor. The device is placed through the trabecular meshwork into Schlemm's canal immediately following placement of a monofocal IOL.

  • Cataract surgeryProcedure

    Cataract surgery performed using standard anesthesia and phacoemulsification techniques

  • Monofocal IOLDevice

    Commercially available monofocal intraocular lens as determined by the investigator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of occurrence of clinically significant device malposition associated with clinical sequelaeTime frame: Day 0 operative, up to Month 24 postoperative

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Vision

    Irvine, California · Completed

  • Sacramento Eye Consultants

    Sacramento, California · Recruiting

  • Eye Center of Northern Colorado

    Loveland, Colorado · Completed

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.